Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingeng Lu

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
Frontiers in Psychology|June 1, 2026
Latent profiles of environmental awareness in Chinese college students: effects of psychological capital and digital engagementYi Liu, Lingeng Lu, Yongcheng Yao
Breast Cancer Research and Treatment|May 11, 2017
Elevated T cell activation score is associated with improved survival of breast cancerLingeng Lu, Yalai Bai, Zuoheng Wang
Breast Cancer Research and Treatment|May 11, 2015
Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survivalLingeng Lu, Hongmei Zeng, Xinsheng Gu, et al.
Avian Diseases|April 21, 2005
Autoinducer 2-like activity in poultry-associated enteric bacteria in response to subtherapeutic antibiotic exposureLingeng Lu, Michael E Hume, Suresh D Pillai
International Journal of Nanomedicine|June 3, 2024
Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition TherapyRui Han, Xiwu Rao, Huiling Zhou, et al.
Nucleic Acids Research|October 9, 2020
tRFtarget: a database for transfer RNA-derived fragment targetsNingshan Li, Nayang Shan, Lingeng Lu, et al.
Breast Cancer (Tokyo, Japan)|July 26, 2022
Neurospora crassa is a potential source of anti-cancer agents against breast cancerRui Han, Hongxing Yang, Changquan Ling, et al.
Scientific Reports|April 22, 2021
Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axisRui Han, Hongxing Yang, Lingeng Lu, et al.
Cancer Cell International|September 16, 2023
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibitionRui Han, Changquan Ling, Yuqian Wang, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?Liqin Yao, Gang Jia, Lingeng Lu, et al.
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
Frontiers in Psychology|June 1, 2026
Latent profiles of environmental awareness in Chinese college students: effects of psychological capital and digital engagementYi Liu, Lingeng Lu, Yongcheng Yao
Breast Cancer Research and Treatment|May 11, 2017
Elevated T cell activation score is associated with improved survival of breast cancerLingeng Lu, Yalai Bai, Zuoheng Wang
Breast Cancer Research and Treatment|May 11, 2015
Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survivalLingeng Lu, Hongmei Zeng, Xinsheng Gu, et al.
Avian Diseases|April 21, 2005
Autoinducer 2-like activity in poultry-associated enteric bacteria in response to subtherapeutic antibiotic exposureLingeng Lu, Michael E Hume, Suresh D Pillai
International Journal of Nanomedicine|June 3, 2024
Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition TherapyRui Han, Xiwu Rao, Huiling Zhou, et al.
Nucleic Acids Research|October 9, 2020
tRFtarget: a database for transfer RNA-derived fragment targetsNingshan Li, Nayang Shan, Lingeng Lu, et al.
Breast Cancer (Tokyo, Japan)|July 26, 2022
Neurospora crassa is a potential source of anti-cancer agents against breast cancerRui Han, Hongxing Yang, Changquan Ling, et al.
Scientific Reports|April 22, 2021
Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axisRui Han, Hongxing Yang, Lingeng Lu, et al.
Cancer Cell International|September 16, 2023
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibitionRui Han, Changquan Ling, Yuqian Wang, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?Liqin Yao, Gang Jia, Lingeng Lu, et al.
Pageof 21